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Abstract
Hemodynamics monitoring provides important information about the performance of the heart, including preload, af-
terload, contractility, and pump efficiency. The most popular techniques used to be based on invasive methods, such as 
the Fick’s formula, thermodilution, and invasive intravascular pressure monitoring, and noninvasive ultrasound-based 
methods such as echocardiography, transesophageal Doppler monitoring of stroke volume, and peripheral arterial 
tonometry. Impedance methods combined with opportunities provided by telemedicine could bring new quality to the 
medical practice.
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Introduction
Conventional, gold standard methods to evaluate haemody-
namic parameters including measurements of stroke volume 
and blood pressures in the vascular bed are associated 
with risks typical for invasive procedures and are limited to 
the hospital settings. A search continues for non-invasive 
methods which could be used in the outpatient settings, with 
automated analysis of the collected data. A widely available 
and established method is echocardiography. However, it is 
characterized be a long learning curve and requires expen-
sive equipment. The ideal method would be reproducible, 
characterized by a short learning curve, feasible in the 
outpatient settings, and relatively inexpensive.
Current efforts focus on several areas. One approach 
is to use techniques based on the evaluation of respiratory 
gases. These measurements may allow evaluation of the 
respiratory function and indirect calculation of haemody-
namic parameters. Based on multiple studies, methods of 
estimating cardiac output based on changes in respiratory 
gas parameters have been introduced to the clinical prac-
tice. The technique of estimating stroke volume based in on 
changes in carbon dioxide in breathing air is described by 
the Gedeon-Capek equation [1, 2]. It has been introduced 
to the clinical practice, e.g., in the intensive care unit of 
the OLVG hospital in Amsterdam [3].
An extension of this technique is the inert gas rebreath-
ing device, the Innocor® CO (Cosmed, Italy) [4]. This de-
vice is filled with a breathing gas mixture containing oxy-
gen, 0.5% nitrous oxide (N2O) and 0.1% sulfur hexafluoride 
(SF6). Measurement of differences in gas concentrations 
during breathing allows calculation of the effective blood 
flow through the pulmonary vascular bed. This stroke vol-
ume measurement method was employed, among others, 
in the Columbia space shuttle. The technique was used 
to study pulmonary blood flow in patients with lung fibro-
sis [5]. Comparison with cardiac output measurements by 
magnetic resonance imaging showed good concordance 
in both lung disease patients and healthy individuals [6].
Carbon dioxide measurements in breathing air were 
also used in studies on the effect of posture on haemody-
namic parameters [7].
Another approach to evaluate the cardiopulmonary 
system using breathing air gas measurements is the car-
diopulmonary exercise test. Assessment of the composi-
tion of the exhaled air during exercise allows calculation of 
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numerous body function parameters. The cardiopulmonary 
exercise test allows evaluation of exercise tolerance and 
provides information regarding the overall body response, 
including pulmonary, cardiovascular, and skeletal muscle 
response to exercise. The obtained metabolic and venti-
lation parameters correlate with increasing symptoms of 
exercise intolerance (dyspnoea, acid-base balance abnor-
malities, and exhaustion) [8–10].
In the 20th century, a method based on measurements 
of impedance changes, with the chest being considered 
a volume conductor of an electric current, was used for the 
first time in studies on the cardiovascular system. During 
application of a 25–100 kHz current, electrical impedance 
changes occurring with changes in blood volume during the 
cardiac cycle are measured. This non-invasive method is 
called impedance cardiography (ICG) or reocardiography.
Physical basis of ICG
The human body is a biological material. The behaviour of 
biological objects in the electric field has specific features. 
Electric current flow through a biological material, a human 
body, generates resistive and capacitive impedance. The 
net effect is called mutual impedance. Each tissue has 
specific characteristics of these impedance components 
during alternating current application, and the frequency 
spectrum of these impedance components allows tissue 
differentiation. These tissues include the circulating blood 
and air within the chest. The mutual relation between these 
two components is called chest impedance.
The parameters used in impedance techniques include 
complex permittivity (describing storage and loss proper-
ties of biological materials when placed in an electric field), 
conductivity, and relative electrical permittivity. Biological 
materials have variable characteristics depending on elec-
tric current frequency, as shown in Figure 1 [11].
Chest impedance includes a component related to 
changes in the circulating blood volume. Blood volume 
changes during the cardiac cycle lead to changes in chest 
electrical impedance. Blood is an inhomogeneous suspen-
sion. Electrical properties and orientation of erythrocytes 
result in changing blood electrical conductivity during circu-
lation phases. During current flow with alpha dispersion in 
the frequency range of 10–100 kHz, erythrocytes generally 
do not conduct an electric current. Brownian motion results 
in their random orientation at rest. An electric current run-
ning along the vessel must be conducted around the erythro-
cytes, which results in low electrical conductivity. Blood flow 
results in parallel erythrocyte orientation. In these settings, 
an electrical current runs against a lower erythrocyte sur-
face, with a resulting increase in conductivity [12]. Electrical 
impedance was found to be related to the haematocrit. Im-
pedance cardiography was used in practice before its theo-
retical physical basis was established. The theoretical basis 
of impedance changes resulting from conductivity changes 
in a given location was developed by Geselowitz [13] and 
Lehr [14], and 8 years later expanded by Moratrelli [15]. The 
recording of changes in chest impedance during the cardiac 
cycle was called impedance cardiography or reocardiography. 
In classical bioimpedance models, the chest was modeled 
as a cylinder or a truncated cone.
The difference between the classical measure-
ment algorithm by Kubiček (chest as a cylinder) and the 
Šramek-Brenstein algorithm (chest as a truncated cone) 
lies in considering a different geometrical solid as an ap-
proximation of the chest shape.
The Kubiček formula (chest as a cylinder) is as follows:
SV — stroke volume; ρ — blood specific electrical resistance 
factor/determined individually based on haematocrit; L — 
distance between electrodes in centimeters; dz/dt max — 
maximum amplitude of the first derivative of impedance (in 
[Ω/s]); Zo — baseline impedance (in [Ω]); T — left ventricular 
ejection time (in [s])
The Šramek-Brenstein formula (chest as a truncated 
cone) is as follows:
SV — stroke volume; ρ — blood specific electrical resistance 
factor/determined individually based on haematocrit; 
L — chess length; dz/dt max — maximum amplitude of 
the first derivative of impedance (in [Ω/s]); Zo — baseline 
impedance (in [Ω]); T — left ventricular ejection time (in [s])
The basic Kubiček formula was modified, yielding the 
Šramek-Brenstein formula [16].
SV = r 
L2 × dz/dt max × T
Zo2
SV = r 
L3 × dz/dt max × T
4.25 Zo
Figure 1. Relative electrical permittivity e’ [mS/cm] of a striated mu-
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Practical applications of ICG
The bioimpedance technique was used to monitor cardiac 
performance and cardiovascular haemodynamics in the as-
tronauts of the Apollo space program [17]. After numerous 
modification, ICG is still used for research purposes [18, 
19]. It was employed in studies in patients with heart fail-
ure, hypertension [20, 21], children with congenital heart 
disease [22], and individuals with sleep apnea [23, 24], 
chronic obstructive pulmonary disease (COPD) [25, 26], 
and pulmonary hypertension [27, 28]. Despite significant 
limitations of ICG [29], the method has been approved by 
the US Food and Drug Administration. The clinical uses of 
ICG covered under the Medicare program (CMS Coverage 
Issues Manual {50–54}, 2005 Federal Register) include:
 — monitoring of fluid balance in heart failure;
 — management of drug-resistant hypertension;
 — adjustment of pacemaker settings;
 — evaluation of patients receiving inotropic drugs;
 — evaluation of patients after cardiac transplantation or 
myocardial biopsy;
 — differentiating between cardiac and pulmonary causes 
of acute dyspnoea.
In Poland, ICG was approved by the National Health 
Fund on Jan 1, 2010 as a useful technique (TISS-28 scor-
ing) for monitoring haemodynamic changes in intensive 
care units. Measurements of changes on electrical chest 
impedance were performed during high frequency alter-
nating current application using the four electrode con-
figuration. For example, the Niccomo™ device (Medis, 
Germany) used four dual application/sensing electrodes 
to apply 1.0–4.0 mA current at 25–75 kHz. The receiving 
electrodes recorded the electrocardiogram and changes 
in electrical impedance.
In the analyses of the results, the following parame-
ters were used:
 — preload — thoracic fluid content (TFC);
 — stroke volume (SV);
 — cardiac output — CO = SV × HR;
 — systolic, diastolic, mean pressure;
 — afterload as described by systemic vascular resist-
ance (SVR).
The above parameters were automatically indexed for 
the body surface area of the studied individual.
Cardiac contractility was described using the follow-
ing parameters:
 — Heather index (the ratio of peak ventricular ejection flow 
[dz/dt max] to the period of increasing first derivative 
of impedance with respect to time [electromechanical 
time interval, or time from the onset of ventricular de-
polarization to dz/dt max]);
 — preejection period (PEP);
 — left ventricular ejection time (LVET);
 — PEP/LVET ratio (Weissler index).
The results were correlated with echocardiographic and 
clinical evaluation.
The PhysioFlow Q-Link device used a different electrode 
configuration (Figure 3 [30]).
Dyspnoea is one of the most common symptoms of 
heart failure. However, differentiating between various 
Figure 2. Impedance cardiogram and electrocardiogram. Temporal and amplitude relations; B — aortic and pulmonary valve opening; 
C (dz/dt max) — peak blood flow through the aortic valve; ECG — electrocardiography; LVET — left ventricular ejection time; O dz/dt — is the 
effect of limited ventricular ability to accommodate venous inflow during early diastole; PEP — preejection period; Q — onset of ventricular 
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causes of dyspnoea continues to be a major challenge in 
the clinical practice. Dyspnoea is the most common symp-
tom in patients presenting to emergency departments. 
Early accurate diagnosis may be of a major importance 
for selecting appropriate treatment. ICG as a non-invasive 
modality for the evaluation of the cardiovascular system 
was studied as a tool to support diagnostic and therapeu-
tic decisions.
In the Impact of Impedance Cardiography on Diagno-
sis and Therapy of Emergent Dyspnea (ED-IMPACT) trial, 
the utility of ICG for differentiating between various causes 
of dyspnoea in the emergency department was evaluated 
[31]. ICG was performed in two academic centres in 89 sub-
jects above 65 years of age who presented with dyspnoea. 
A complete clinical examination was performed, and hae-
modynamic parameters obtained from ICG in the emergen-
cy department were analyzed. ICG had been performed be-
fore laboratory test and chest X-ray results were available. 
The number of changes in diagnoses and treatment modi-
fications following unblinding of ICG haemodynamic data 
was evaluated. A comparison of haemodynamic parameters 
showed significant differences between the group with pre-
dominant heart failure and the groups with COPD and other 
conditions (p < 0.02). Thoracic fluid content was highest in 
the group with heart failure (38.5 ± 12.3 vs. 30.0 ± 6.17 vs. 
30.4 ± 5.6 kOhm–1, respectively). SVR was highest in the 
group with heart failure (1772 ± 565 vs. 1361 ± 407 vs. 
1789 ± 638 dyn × sec × cm–5, respectively).
The cardiac index (CI) was highest in the group with 
COPD (2.39 ± 0.56 vs. 3.08 ± 0.57 vs. 2.48 ± 0.65 L/ 
/min/m2, respectively).
Patients with heart failure had higher SVR, TFC, and low-
er CI, while patients with COPD had low TFC, SVR, and high-
er CI. Exacerbated heart failure and COPD were the final di-
agnoses in 43 (48%) and 20 (22%) patients, respectively. 
Data from ICG changed the diagnosis in 12 patients [13%; 
95% confidence interval (CI) 7% to 22%] and the therapy in 
35 patients (39%; 95% CI 29% to 50%). The authors noted 
that this simple test clearly supported diagnostics and ther-
apeutic decisions.
Another randomized IMPEDANCE-HF trial evaluated 
whether lung impedance monitoring would reduce hospi-
talizations in patients with acute exacerbated heart fail-
ure. This blinded study was performed in two centres [32]. 
The study included 256 patients with chronic heart failure 
and, reduced left ventricular ejection fraction (≤ 35%) and 
New York Heart Association (NYHA) class II–IV symptoms. 
All patients were hospitalized due to acute exacerbated 
heart failure during the previous 12 months. They were 
randomized to the impedance monitoring group or the 
usual care group. Telemedical thoracic fluid content mo-
nitoring was performed using the electrode configuration 
shown in Figure 4.
The primary endpoint was hospitalization due to exac-
erbation of the primary condition. Secondary endpoints 
were hospitalizations due to other causes and deaths. Sig-
nificantly fewer patients were readmitted in the monitor-
ing group (67 vs. 158, p < 0.001), with lower cardiac and 
overall mortality. These results suggest that the impedance 
monitoring is useful in the outpatient setting.
Other authors used a four-electrode configuration to 
study changes in thoracic fluid content, particularly in 
lungs. Two electrodes (current and voltage) are placed 
below the right scapular angle, and two more below the 
right clavicle in the right parasternal line. Changes in elec-
trical impedance compared to the measurement at the 
optimal clinical status of the patient indicate an increase 
or reduction of thoracic fluid content [33]. An increase 
in thoracic fluid content results in an impedance drop 
compared to baseline, while a decrease in thoracic flu-
id content will be reflected by an increase in impedance. 
In the study, a telemetric system to monitor changes in 
Figure 3A, B. Chest electrode configuration for the measurements of chest impedance changes using the PhysioFlow Q-Link device (Manatec 
Biomedical, Paris, France). The scheme and photography from the author’s own research; Z1, Z4 — current electrodes; Z2, Z3 — voltage 
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lung fluid content was used. Data obtained during 90-day 
monitoring in patients discharged after heart failure de-
compensation were compared to a similar period without 
monitoring. A reduction in the hospitalization rate by 87% 
in men and 79% in women was found in the monitoring 
group. The authors concluded that telemetric lung fluid 
content monitoring had a significant diagnostic potential 
to reduce the rate of recurrent admissions for acute de-
compensated heart failure.
Another group of authors evaluated the utility of tele-
medical chest impedance measurements to detect fluid 
accumulation. The recorded data were automatically sent 
via a cellular phone to the monitoring center. The monitor-
ing was undertaken in 106 patients for 45 days, followed 
by a follow-up of 75 days. The algorithm used was found to 
be 87% sensitive and 70% specific. As highlighted by the 
authors, the study subjects transmitted data on thoracic 
fluid content changes daily without any significant techni-
cal issues [34].
Use of telemetric systems has been a subject of stud-
ies undertaken by The National Centre for Research and 
Development in Poland. ICG was used to monitor car-
diac performance in patients with ischaemic stroke in 
the PBS2/A3/17/2013 project “Internet platform for 
data integration and cooperation of medical research 
teams for the purposes of stroke units”. Currently, the 
STRATEGMED3/305274/8/NCBR/2017 project is un-
derway under the AMULET acronym [35], “A new model 
of medical care using modern techniques of noninvasive 
clinical evaluation and telemedicine in patients with heart 
failure”. Impedance methods were used to monitor therapy 
in patients with heart failure. In this randomized study, the 
effect of ICG monitoring on cardiovascular mortality and 
recurrent hospitalizations due to acute decompensated 
heart failure compared to usual care is being evaluated in 
nine centers in Poland. The primary combined endpoint in-
cludes cardiovascular deaths and/or hospitalizations due 
to exacerbation of the primary condition.
Studies on the use of noninvasive techniques to mon-
itor haemodynamic changes during the exercise test were 
carried out in several centres. A major problem is the se-
lection of the measurement technique for practical stud-
ies. For this purpose, four techniques were compared si-
multaneously:
 — conventional Fick technique;
 — ICG using the PhysioFlow device;
 — pulse contour analysis;
 — measurements of changes in breathing gas composi-
tion (Innocor — rebreathing).
Values obtained using the Innocor device were lower, 
and those obtained by ICG were higher compared to other 
techniques. The authors concluded that the precision of 
cardiac output measurements depended on the technique 
used [36]. Other authors simultaneously used ICG and the 
indocyanine green dye dilution method (CODD) during the 
exercise test in patients with COPD. A strong correlation 
between measurements using these two techniques was 
noted in 50 patients [37].
Intrathoracic impedance measurement  
in patients with a cardiac pacemaker
In 2003, encouraging results regarding the use of an ICG 
device incorporated into a cardiac pacemaker were pub-
lished by the research group of Patterson and Wang. These 
authors hypothesized that a device measuring impedance 
between the pacemaker casing and the pacemaker lead 
would provide information on the changes in water content 
in the lung tissue [38]. A computer software automatically 
calculates a specific impedance curve in an individual pa-
tient, providing a measure of water content called the fluid 
index. Exceedance of the critical level of thoracic water con-
tent is signaled by the peripheral device. Studies showed 
that intrathoracic impedance measurements in patients 
with heart failure and an implantable cardioverter-defi-
brillator allowed early detection of acute decompensated 
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heart failure. The devices to monitor thoracic fluid content 
incorporated into implantable cardiac devices continue to 
be modified [39, 40].
Summary
Noninvasive methods, including the impedance techniques, 
continue to be developed. The impedance techniques 
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Streszczenie
Monitorowanie hemodynamiczne dostarcza istotnych informacji o wydolności serca — obciążeniu wstępnym, następ-
czym, kurczliwości serca, wydajności „pompy sercowej”. Najbardziej popularne techniki obejmowały pomiary metodami 
inwazyjnymi — Ficka, termodylucji i pomiary inwazyjnych ciśnień w łożysku sercowo-naczyniowym oraz metodami niein-
wazyjnymi opartymi na technikach ultradźwiękowych — echokardiografii, przezprzełykowym doplerowskm monitorowaniu 
przepływu przez aortę wstępującą oraz tonometrii aplanacyjnej. Połączenie metod impedancynych z możliwością analizy 
telemedycznej wyników może stworzyć nową wartość w praktyce lekarskiej.
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have been introduced in the outpatient settings for the 
monitoring of haemodynamic changes as the indices of 
cardiac performance.
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